These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33879161)

  • 1. Variations in biomarkers of dyslipidemia and dysbiosis during the menstrual cycle: a pilot study in healthy volunteers.
    Bergström H; Ekström L; Warnqvist A; Bergman P; Björkhem-Bergman L
    BMC Womens Health; 2021 Apr; 21(1):166. PubMed ID: 33879161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on CYP3A activity during the menstrual cycle as measured by urinary 6β-hydroxycortisol/cortisol.
    Bergström H; Lindahl A; Warnqvist A; Diczfalusy U; Ekström L; Björkhem-Bergman L
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00884. PubMed ID: 34664787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Postprandial Serum Triglyceride and Apolipoprotein B Concentrations between the Two Phases of Menstrual Cycle in Healthy Women.
    Tzeravini E; Tentolouris A; Eleftheriadou I; Chaviaras N; Kolovou G; Apostolidou-Kiouti F; Stratigakos E; Tentolouris N
    Curr Vasc Pharmacol; 2021; 19(4):411-422. PubMed ID: 32525776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Menstrual Cycle Phases on Plasma Lipid and Lipoprotein Levels in Regularly Menstruating Women.
    Vashishta S; Gahlot S; Goyal R
    J Clin Diagn Res; 2017 May; 11(5):CC05-CC07. PubMed ID: 28658753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-Tocopherol concentrations in plasma but not in lipoproteins fluctuate during the menstrual cycle in healthy premenopausal women.
    Lanza E; Forman MR; Johnson EJ; Muesing RA; Graubard BI; Beecher GR
    J Nutr; 1998 Jul; 128(7):1150-5. PubMed ID: 9649599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipid and lipoprotein levels during the follicular and luteal phases of the menstrual cycle.
    Barnett JB; Woods MN; Lamon-Fava S; Schaefer EJ; McNamara JR; Spiegelman D; Hertzmark E; Goldin B; Longcope C; Gorbach SL
    J Clin Endocrinol Metab; 2004 Feb; 89(2):776-82. PubMed ID: 14764796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic changes in lipoprotein and apolipoprotein levels during the menstrual cycle in healthy premenopausal women on a controlled diet.
    Muesing RA; Forman MR; Graubard BI; Beecher GR; Lanza E; McAdam PA; Campbell WS; Olson BR
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3599-603. PubMed ID: 8855808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High density lipoprotein concentration is increased during the ovulatory phase of the menstrual cycle in healthy young women.
    Azogui G; Ben-Shlomo I; Zohar S; Kook A; Presser S; Aviram M
    Gynecol Endocrinol; 1992 Dec; 6(4):253-7. PubMed ID: 1492580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in serum lipids, lipoproteins, sex hormone binding globulin and testosterone between the follicular and the luteal phase of the menstrual cycle.
    Schijf CP; van der Mooren MJ; Doesburg WH; Thomas CM; Rolland R
    Acta Endocrinol (Copenh); 1993 Aug; 129(2):130-3. PubMed ID: 8372597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
    Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A
    Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.
    Fonseca L; Paredes S; Ramos H; Oliveira JC; Palma I
    Lipids Health Dis; 2020 Jun; 19(1):127. PubMed ID: 32505210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
    Magkos F; Patterson BW; Mittendorfer B
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1243-9. PubMed ID: 16835398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
    J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the hormonal changes during the normal menstrual cycle in healthy young women on soluble adhesion molecules, plasma homocysteine, free radical markers and lipoprotein fractions.
    Elhadd TA; Neary R; Abdu TA; Kennedy G; Hill A; McLaren M; Akber M; Belch JJ; Clayton RN
    Int Angiol; 2003 Sep; 22(3):222-8. PubMed ID: 14612848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines.
    Sathiyakumar V; Park J; Quispe R; Elshazly MB; Michos ED; Banach M; Toth PP; Whelton SP; Blumenthal RS; Jones SR; Martin SS
    Circulation; 2018 Jul; 138(3):244-254. PubMed ID: 29506984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B vs non-high-density lipoprotein cholesterol: Association with endothelial hemostatic markers and carotid intima-media thickness.
    Karasek D; Vaverkova H; Cibickova L; Gajdova J; Kubickova V
    J Clin Lipidol; 2017; 11(2):442-449. PubMed ID: 28502501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.